Red Raspberry Leaf — Benefits Deep Dive

Red raspberry leaf is the dried leaf of Rubus idaeus — the same plant that produces raspberries, but a different organ with a different chemistry and a completely different reputation. For at least two centuries it has been the archetypal “pregnancy tea,” recommended by midwives and grandmothers in the last weeks before birth to tone the uterus. It is also a traditional tea for menstrual cramps, and it is marketed almost everywhere as being “rich in vitamins and minerals.”

These four deep-dive pages exist because that reputation and the published evidence do not match, and because readers act on this particular herb while pregnant. When someone drinks chamomile because a website oversold it, very little is at stake. When someone drinks raspberry leaf at 30 weeks because a website told them it “brings on labour,” the stakes are different. So these pages do something the marketing copy does not: they name the actual studies, say how big and how well designed they were, do the arithmetic on the nutrient claims instead of repeating them, and report the parts of the laboratory record that contradict the traditional story rather than quietly leaving them out.

The short version, before you read any further: raspberry leaf has no clearly demonstrated benefit for labour; the small body of clinical work is reassuring rather than conclusive on safety; no study shows it starts labour, and the one randomized trial found it did not shorten the first stage of labour; and the nutrient content of a cup of the infusion is genuinely small. It is a pleasant, low-risk, caffeine-free tea with a long tradition behind it. That is a real thing to be. It is not the same thing as a proven remedy.


Table of Contents

  1. Deep-Dive Articles
  2. First Principle: the Leaf Is Not the Berry
  3. What Each Claim Actually Rests On
  4. The Contradiction at the Centre of the Story
  5. Who Uses It, and What They Are Told
  6. How to Read These Pages
  7. Key Research Papers
  8. External Resources
  9. Connections
  10. Featured Videos

Deep-Dive Articles

First Principle: the Leaf Is Not the Berry

Almost every piece of misinformation about this herb traces back to a single confusion. Rubus idaeus produces a fruit that is a genuinely good food — sweet, high in vitamin C and fibre, full of anthocyanins and ellagitannins. It also produces a leaf. The leaf is what goes into the tea, and it is chemically a different material: more tannin, more flavonol glycoside, no meaningful sugar, no anthocyanin pigment to speak of, and a very different mineral picture.

When a product page says raspberry leaf tea is “packed with vitamin C,” the number underneath that claim has usually walked across from a fruit database. It should not have. Two further steps break the claim even for the leaf: the leaf is dried, which destroys much of its ascorbic acid, and then it is infused, so you drink only what water pulls out of two or three grams of plant material in ten minutes. You are not eating the leaf. You are drinking a dilute extract of a very small amount of it.

This is not a pedantic distinction. It is the difference between “this tea is a source of calcium in pregnancy” — which is not true in any nutritionally useful sense — and “this tea is a nice caffeine-free drink,” which is true. The nutrients page does the arithmetic in full, and links across to raspberries for the fruit, which is where the good nutrition data actually lives.

What Each Claim Actually Rests On

Every claim made for raspberry leaf sits in one of four evidence tiers. Labelling them is the most useful thing this hub can do, because the marketing never does:

A third human study has since been published. A 2024 prospective observational study from a different Australian group followed 91 women, 44 who used raspberry leaf and 47 who did not. A smaller proportion of the users had their labour medically sped up (augmentation), an epidural, an instrumental birth, a caesarean section or heavy bleeding after the birth (postpartum haemorrhage), and all phases of labour were shorter. The authors state that the results “cannot be relied on or generalised to the wider population of pregnant women,” and that the absence of safety concerns “should not be taken as evidence that raspberry leaf is safe”; they call a randomised controlled trial urgently needed.

The Contradiction at the Centre of the Story

Herbal writing usually describes raspberry leaf as containing fragarine, an alkaloid that “tones” the uterus — strengthening the muscle so contractions become more coordinated and effective. It is an appealing story. It is also doing something no drug does: relaxing a muscle and strengthening its contractions at the same time, on demand, in whichever direction the situation requires.

The laboratory record is where that story came from and it is genuinely split. In 1941 The Lancet published work by Burn and Withell describing a principle in raspberry leaves that relaxed uterine muscle, and the same year the British Medical Journal carried Whitehouse’s account of fragarine as an inhibitor of uterine action. Later pharmacology, including work published in the British Journal of Pharmacology in 1970 by Bamford and colleagues, found that the direction of the effect depended on the preparation and on the state of the tissue — quiescent muscle could be stimulated while already-contracting muscle was calmed. Subsequent extract work, such as a study of relaxant activity in guinea-pig ileum published in Phytotherapy Research in 2002, again found smooth-muscle relaxation rather than stimulation.

So the honest summary is not “raspberry leaf tones the uterus.” It is: extracts of the leaf do something to isolated smooth muscle, the direction is inconsistent, none of it was measured in a pregnant human, and the one trial that measured actual labour found no significant effect on the outcome that mattered most. The traditional word “tonic” survives partly because it is vague enough to accommodate a contradiction. That is worth noticing rather than repeating.

Who Uses It, and What They Are Told

Raspberry leaf is one of the most-used herbal products in pregnancy in surveys from the United Kingdom and Australia. Surveys of herbal use in pregnancy — including work by Holst and colleagues published in The Journal of Alternative and Complementary Medicine in 2009, and Nordeng and colleagues’ Norwegian survey of 600 women in Complementary Therapies in Clinical Practice in 2011 — find that a large share of pregnant women use herbal products (39.7% in the Norwegian survey), and that a substantial fraction do not tell their maternity provider. In the Holst survey of 578 pregnant women at a hospital antenatal clinic in the United Kingdom, 57.8% had used herbal remedies during pregnancy, ginger, cranberry and raspberry leaf were the most commonly used, “family and friends” were the most frequently cited source of information, and more than 75% of users did not tell their doctor or midwife. In the Norwegian survey the most common herbs were ginger, iron-rich herbs, echinacea and cranberry, and there was a significant association between the use of raspberry leaves and caesarean delivery. Advice usually comes from friends, family, forums and shop staff rather than from a clinician.

A 2026 Australian survey of 561 pregnant women found that 68% reported taking one or more herbal medicines during their pregnancy, a larger percentage than older Australian surveys had reported; raspberry leaf was the most common herb, used by 37%, and the most common reason given for using it was to make labour easier.

That pattern is exactly why the tone of these pages matters. Telling a reader who has already bought the tea that herbs are dangerous nonsense achieves nothing except that she stops mentioning it to her midwife. Telling her the truth — the tradition is real, the evidence is thin, here is what is known about timing and cautions, and here is the one sentence to say at your next appointment — is more useful and more likely to be acted on.

How to Read These Pages

Every claim on the four sub-articles carries an evidence label: randomized clinical trial, preliminary (animal or in-vitro), traditional use only, or insufficient evidence. Where a figure is uncertain, the page says so and links a PubMed topic search rather than asserting a number.

Each reference below names the paper — authors, title, journal, year — and was checked against its PubMed record; the link at the end is that record’s PubMed ID (PMID), or, for a 1941 Lancet paper that PubMed does not index, its DOI. A few entries describe a body of work rather than a single paper, and those link a PubMed topic search instead. Where our description of a study and the PubMed record differ, the record is the authority.

Back to Table of Contents

Key Research Papers

1. Pregnancy and labour: the whole clinical evidence base

This is a genuinely small literature: two Australian studies from one research group (1999 and 2001), a 2024 prospective observational study by a different Australian group, and the reviews that assess them.

  1. Parsons M, Simpson M, Ponton T. “Raspberry leaf and its effect on labour: safety and efficacy.” Australian College of Midwives Incorporated Journal, 1999. Retrospective, 108 mothers in all (57 who took raspberry leaf products, 51 controls); suggested shorter labour and fewer interventions among users, but could not exclude that women who choose herbal tea differ in other ways. — PubMed PMID: 10754818
  2. Simpson M, Parsons M, Greenwood J, Wade K. “Raspberry leaf in pregnancy: its safety and efficacy in labor.” Journal of Midwifery & Women’s Health, 2001. The only randomized, double-blind, placebo-controlled trial; no significant effect on first-stage labour, modest secondary differences, no harm observed. — PubMed PMID: 11370690
  3. Bowman RL, Taylor J, Davis DL. “Raspberry leaf (Rubus idaeus) use in pregnancy: a prospective observational study.” BMC Complementary Medicine and Therapies, 2024. 91 women (44 users, 47 non-users); fewer augmentations and interventions among users, results stated by the authors to be not generalisable. — PubMed PMID: 38649906
  4. Holst L, Haavik S, Nordeng H. “Raspberry leaf — should it be recommended to pregnant women?” Complementary Therapies in Clinical Practice, 2009. Answers its own question with: the evidence is too limited to recommend it. — PubMed PMID: 19880082
  5. Bowman R, Taylor J, Muggleton S, Davis D. “Biophysical effects, safety and efficacy of raspberry leaf use in pregnancy: a systematic integrative review.” BMC Complementary Medicine and Therapies, 2021. The most recent synthesis; no clear benefit demonstrated, no strong safety signal either way. — PubMed PMID: 33563275

2. Uterine and smooth-muscle pharmacology

All preliminary — isolated tissue, animal models, and papers old enough that the methods would not be accepted today.

  1. Burn JH, Withell ER. “A principle in raspberry leaves which relaxes uterine muscle.” The Lancet, 1941;238(6149):1–3. The origin of the relaxant half of the story. — doi:10.1016/S0140-6736(00)71348-1
  2. Whitehouse B. “Fragarine: an inhibitor of uterine action.” British Medical Journal, 1941. Where the named constituent enters the literature — as an inhibitor, note, not a strengthener. — PubMed PMID: 20783856
  3. Bamford DS, Percival RC, Tothill AU. “Raspberry leaf tea: a new aspect to an old problem.” British Journal of Pharmacology, 1970 (proceedings abstract). Reported that the direction of effect depends on preparation and on whether the tissue was already active. — PubMed PMID: 5487014
  4. Rojas-Vera J, Patel AV, Dacke CG. “Relaxant activity of raspberry (Rubus idaeus) leaf extract in guinea-pig ileum in vitro.” Phytotherapy Research, 2002. Guinea-pig ileum rather than uterus, but again relaxation. — PubMed PMID: 12410549

3. Leaf phytochemistry and antioxidant chemistry

The best-established part of the whole picture — and note it is chemistry, not clinical benefit.

  1. Ferlemi AV, Lamari FN. “Berry leaves: an alternative source of bioactive natural products of nutritional and medicinal value.” Antioxidants, 2016. A review of what is actually in berry leaves, raspberry included. — PubMed PMID: 27258314
  2. Analytical work on flavonoids, tannins and ellagic acid in Rubus leaves — the ellagitannin and flavonol-glycoside profile that gives the tea its astringency. — Search PubMed
  3. Antioxidant capacity of raspberry leaf infusions measured in vitro — real, reproducible, and not evidence of a health outcome. — Search PubMed
  4. Tannins and non-haem iron absorption — the reason tannin-rich teas are reported to reduce iron absorption when taken with meals or iron tablets. — Search PubMed

4. Safety signals: case reports and animal data

  1. Cheang KI, Nguyen TT, Karjane NW, Salley KES. “Raspberry leaf and hypoglycemia in gestational diabetes mellitus.” Obstetrics & Gynecology, 2016. A single case report — the weakest study design there is, and still the specific reason the diabetes caution exists. — PubMed PMID: 27824754
  2. Johnson JR, Makaji E, Ho S, Xiong B, Crankshaw DJ, Holloway AC. “Effect of maternal raspberry leaf consumption in rats on pregnancy outcome and the fertility of the female offspring.” Reproductive Sciences, 2009. Rat data; the reason a careful writer will not say the herb is simply safe. — PubMed PMID: 19276407
  3. Animal glucose-lowering data for Rubus leaf preparations — the basis of the theoretical interaction with diabetes medication. — Search PubMed

5. Herbal use in pregnancy: surveys and safety reviews

  1. Holst L, Wright D, Haavik S, Nordeng H. “The use and the user of herbal remedies during pregnancy.” The Journal of Alternative and Complementary Medicine, 2009. — PubMed PMID: 19538045
  2. Nordeng H, Bayne K, Havnen GC, Paulsen BS. “Use of herbal drugs during pregnancy among 600 Norwegian women in relation to concurrent use of conventional drugs and pregnancy outcome.” Complementary Therapies in Clinical Practice, 2011. — PubMed PMID: 21742280
  3. Bowman RL, Davis DL, Taylor J. “Beyond prescription medicine in pregnancy — raspberry leaf and other herbs in Australia.” BMC Complementary Medicine and Therapies, 2026. — PubMed PMID: 41668030
  4. Muñoz Balbontín Y, Stewart D, Shetty A, Fitton CA, McLay JS. “Herbal medicinal product use during pregnancy and the postnatal period: a systematic review.” Obstetrics & Gynecology, 2019. — PubMed PMID: 30969204
  5. Dante G, Bellei G, Neri I, Facchinetti F. “Herbal therapies in pregnancy: what works?” Current Opinion in Obstetrics & Gynecology, 2014. — PubMed PMID: 24535321
  6. Ernst E. “Herbal medicinal products during pregnancy: are they safe?” BJOG, 2002. — PubMed PMID: 11950176

Back to Table of Contents

Back to Table of Contents

External Resources

Connections


Information, not medical advice. This hub and its sub-articles describe what has and has not been shown about a traditional herbal tea. Nothing here is antenatal advice, a treatment plan, or a substitute for care from a midwife, obstetrician or physician. The safety findings that matter most for anyone who is pregnant, trying to conceive, breastfeeding, taking medication for diabetes or blood clotting, or managing a pregnancy complication are these: a 2016 case report describes a woman with gestational diabetes who developed low blood sugar needing a lower insulin dose after she began drinking raspberry leaf tea; a Norwegian survey of 600 women found an association between raspberry leaf use and caesarean delivery; and in rats, raspberry leaf during pregnancy was associated with longer gestation. Contractions before 37 weeks, bleeding, fluid loss and reduced fetal movement are signs that maternity units treat as urgent.

Back to Table of Contents